These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistance. Chen HY, Livermore DM. J Antimicrob Chemother; 1994 Mar; 33(3):453-64. PubMed ID: 8040111 [Abstract] [Full Text] [Related]
9. Potent activity of meropenem against Escherichia coli arising from its simultaneous binding to penicillin-binding proteins 2 and 3. Sumita Y, Fukasawa M. J Antimicrob Chemother; 1995 Jul; 36(1):53-64. PubMed ID: 8537284 [Abstract] [Full Text] [Related]
10. Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Yano H, Kuga A, Okamoto R, Kitasato H, Kobayashi T, Inoue M. Antimicrob Agents Chemother; 2001 May; 45(5):1343-8. PubMed ID: 11302793 [Abstract] [Full Text] [Related]
11. SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases. Queenan AM, Shang W, Schreckenberger P, Lolans K, Bush K, Quinn J. Antimicrob Agents Chemother; 2006 Oct; 50(10):3485-7. PubMed ID: 17005839 [Abstract] [Full Text] [Related]
15. Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens. Ito H, Arakawa Y, Ohsuka S, Wacharotayankun R, Kato N, Ohta M. Antimicrob Agents Chemother; 1995 Apr; 39(4):824-9. PubMed ID: 7785978 [Abstract] [Full Text] [Related]
16. [In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998]. Watanabe A, Tokue Y, Takahashi H, Kikuchi T, Kobayashi T, Gomi K, Fujimura S, Yasui S, Nukiwa T, Shoji S, Honda Y. Jpn J Antibiot; 1999 Dec; 52(12):690-4. PubMed ID: 10695024 [Abstract] [Full Text] [Related]
17. Biochemical characterization of a beta-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates. Yang YJ, Wu PJ, Livermore DM. Antimicrob Agents Chemother; 1990 May; 34(5):755-8. PubMed ID: 2193618 [Abstract] [Full Text] [Related]
18. Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials. Iaconis JP, Pitkin DH, Sheikh W, Nadler HL. Clin Infect Dis; 1997 Feb; 24 Suppl 2():S191-6. PubMed ID: 9126693 [Abstract] [Full Text] [Related]
19. Relative importances of outer membrane permeability and group 1 beta-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae. Cornaglia G, Russell K, Satta G, Fontana R. Antimicrob Agents Chemother; 1995 Feb; 39(2):350-5. PubMed ID: 7726496 [Abstract] [Full Text] [Related]